Itau Unibanco Holding S.A. Exelixis, Inc. Transaction History

Itau Unibanco Holding S.A.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$20.34 - $23.73 $5,695 - $6,644	280 New	280 $6,000
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $2,290 - $2,871	-119 Reduced 19.97%	477 $11,000
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $3,343 - $3,768	-184 Reduced 23.59%	596 $11,000
Q4 2022 Feb 09, 2023	SELL	$14.96 - $17.39 $45,852 - $53,300	-3,065 Reduced 79.71%	780 $12,000
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $24,272 - $34,473	-1,548 Reduced 28.7%	3,845 $60,000
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $3,924 - $5,211	-225 Reduced 4.0%	5,393 $112,000
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $34,832 - $48,114	2,199 Added 64.32%	5,618 $105,000
Q3 2021 Nov 12, 2021	BUY	$16.3 - $21.14 $15,957 - $20,696	979 Added 40.12%	3,419 $72,000
Q2 2021 Aug 17, 2021	BUY	$17.95 - $25.56 $43,798 - $62,366	2,440 New	2,440 $44,000
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $39,158 - $65,232	-2,379 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $26,837 - $40,460	1,856 Added 354.88%	2,379 $41,000
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $7,923 - $9,879	523 New	523 $9,000
Q3 2018 Nov 13, 2018	SELL	$15.87 - $22.4 $134,879 - $190,377	-8,499 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$18.56 - $22.45 $458,673 - $554,806	-24,713 Reduced 74.41%	8,499 $183,000
Q1 2018 May 14, 2018	BUY	$22.15 - $31.89 $106,763 - $153,709	4,820 Added 16.98%	33,212 $736,000
Q4 2017 Feb 09, 2018	BUY	$24.23 - $30.93 $687,938 - $878,164	28,392	28,392 $863,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.